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Abstract: Metabolic syndrome has been considered a factor of vulnerability and a major public health
problem because it increases the risk of cardiovascular disease and type 2 diabetes. The present study
from Amazonas, Brazil aimed to estimate the prevalence of the individual and general components of
metabolic syndrome in adults and older adults and identify the independent predictors of metabolic
syndrome. The sample of the present cross-sectional study comprised 942 participants (590 women),
with a mean age of 59.8 ± 19.7 (range: 17.5 to 91.8). Blood pressure in men (62.5%), abdominal obesity
in women (67.3%), and lower high-density lipoprotein cholesterol (HDL-C) in both (52.2% in men and
65.0% in women) were the most prevalent individual risk factors for metabolic syndrome. Women
had a higher prevalence of abdominal obesity (p < 0.001), low HDL-C (p < 0.001), and metabolic
syndrome (p < 0.001) than men; however, opposite results were seen in men for blood pressure
(p < 0.001). The overall prevalence of metabolic syndrome was 47.5%. Advanced age, being female,
having a higher body mass index, and a having lower educational level independently increased
the odds of metabolic syndrome. Due to the association of metabolic syndrome with deterioration
of health status and increased vulnerability, this study sustains the need for early public health
interventions in the Amazonas region.
Keywords: cardiometabolic risk factors; health status; vulnerability; sex-related differences; public
health; Amazona—Brazil
1. Introduction
Metabolic syndrome is a clustering of interrelated cardiometabolic risk factors, which
more often occur together than individually [1]. The metabolic abnormalities that char-
acterize metabolic syndrome include increased blood pressure, elevated blood glucose,
excess body fat around the waist, and abnormal cholesterol or triglyceride levels [2].
The current literature claims metabolic syndrome as a factor of vulnerability [3–5]
and a major public health problem, the prevalence of which is increasing worldwide [6–9].
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Individuals with metabolic syndrome are 2.5 times more likely to die from cardiovascular
disease compared with their peers with no metabolic syndrome [10]. Additionally, these
individuals are five times more vulnerable to develop type 2 diabetes mellitus [11].
In the last decade, several studies have contributed to estimating the prevalence of
metabolic syndrome and its risk factors. This mapping has vital importance in early risk
identification and increases the effectiveness of specific interventions aimed to prevent fu-
ture deterioration of the health status. In Brazil, a representative sample analysis (National
Health Survey in 2013) showed a prevalence of metabolic syndrome of 7.5% in men and
10.3% in women [12]. de Carvalho Vidigal [13] in a systematic review including healthy
Brazilian adults aged between 19 and 64 years old, reported a prevalence of 29.6% for
metabolic syndrome. In this review, 10 studies were considered; however, none of them
gathered information from the Amazonas region. The prevalence reported in this review for
the context of Brazil context was higher than the average of the world’s adult population,
which is estimated between 20 and 25% [11]. However, the higher prevalence was seen in
Portugal (47.2%, similar in females and males; [14]), in Indonesia (28% in men and 46% in
women), and in the Netherlands (36% in men and 24% in women; [15]). Our study, using a
reliable methodology to diagnose metabolic syndrome, adds knowledge to this topic in the
Amazonas region, where information is scarce. To the best of our knowledge, this is the
first study in a large adult lifespan sample from this region of Brazil. This issue reaches
greater importance in this particular region because it is characterized by socioeconomic
and health inequalities, which place serious challenges on the health public system [16].
Among the modifiable explanatory factors for this phenomenon, the increase in obesity
and the adoption of sedentary lifestyles during past decades has been highlighted [12,17,18].
Other factors have also been shown to play a role in the development of metabolic syn-
dromes, such as individual variables (i.e., sex), genetic predisposition [19], smoking and
unhealthy eating patterns [18], aging [13], and contextual involvement [12]. However, such
relationships are not fully understood so far in the literature. For example, concerning
sex-related differences, some studies have not found any differences between men and
women [20–23]. Others have reported a higher prevalence of metabolic syndrome among
men compared to women [15,24], and others found a higher prevalence in women com-
pared with men [25–27]. These contradictory results can open new avenues in the research
for possible explanations that go beyond the differences associated with the hormone levels
commonly accepted [28].
There is a consensus in the literature that older age, a lower education level, low phys-
ical activity, and higher a body mass index increase the odds of metabolic syndrome [28].
First, the age-related increase in the prevalence of metabolic syndrome is significantly
influenced by the large prevalence of metabolic risk factors developed at the oldest ages,
in particular >65 years [29]. Second, the most disadvantaged people who had a lower
education level, were unemployed, and of a lower income level had more vulnerability
to develop metabolic syndrome [30]. Third, engagement in regular physical activity has
been considered an important lifestyle intervention to prevent metabolic syndrome. Some
studies have proved that regular physical activity reduces risk factors related to metabolic
syndrome and associated vascular diseases [31]. However, the relationships between physi-
cal activity and metabolic syndrome seem to be dependent on factors related to the type and
intensity of physical activity as well as individual variables and contextual involvement.
Finally, the clustering of multiple risk components within metabolic syndrome is widely
thought to occur as a result of obesity, specifically, abdominal obesity [32].
Information on the prevalence of metabolic syndrome and its relationship with inde-
pendent predictors, such as demographics, lifestyle, and clinical measures, needs more
clarification, in particular among the population of the state of Amazonas. Thus, the
present study aimed to estimate the prevalence of the individual and general components
of metabolic syndrome, considering sex-related differences, and assess the impact of age,
sex, BMI, education level, and physical activity on the likelihood that participants present
metabolic syndrome.
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2. Methods
2.1. Sample and Study Design
The sample of the present cross-sectional study comprised 942 participants (352 men
and 590 women), with a mean age of 59.8 ± 19.7 years (range: 17.5 to 91.8). From those,
only 910 participants (569 women) fulfilled all the criteria for the diagnosis of metabolic
syndrome. Data were obtained from the Health, Lifestyle, and Functional Fitness in the
Adult and Older People from Amazonas, Brazil (SEVAAI) study. Data were collected be-
tween 2016 and 2017. Participants were volunteers recruited via advertisements distributed
through newspapers, local radio, churches, schools, and senior centers. The inclusion crite-
ria were living in one of three geographic areas of Brazil (Fonte Boa, Apuí, and Manaus),
voluntary motivation to participate in the study, and being able to walk independently.
The only exclusion criterion was the inability to understand and follow the assessment
protocol of the study. For the sample size calculation, we used the GPower, (Heinrich-
Heine-University, Düsseldorf, Germany; 3.1.9.7 software) [33]. A priori, logistic regression
analysis indicated that a total sample size of 824 participants was needed to achieve 85%
power and an odds ratio of 1.3 at the 0.05 level of significance. All participants gave
informed consent, and the present study included adherence to the declaration of Helsinki
and had been approved by the local ethics commission (CAAE: 56519616.6.0000.5016;
Number: 1.599.258; Brazil Platform).
2.2. Instruments
2.2.1. Clinical Analysis
Several clinical parameters were assessed by specialized clinical analysis laboratory
technicians; in particular, glucose level, high- and low-density lipoproteins (HDL and LDL,
respectively), and triglycerides. Blood was collected by venipuncture from all participants,
in a fasted state (more than 8 h), between 7 am and 9 am. For this purpose, needles were
used, as well as syringes and collection tubes. After collecting 7 mL of blood from the
antecubital vein to a dry tube with silica gel, i.e., an accelerator of serum separation, the
tubes were identified and transported to the laboratory. After an hour of rest, the serum
was separated by centrifugation at room temperature for 15 min at 3500 rotations per
minute.
2.2.2. Blood Pressure
After 20 min of rest, blood pressure was assessed (OMRON M6 HEM-7001-E; Omron
Corporation, Kyoto, Japan). Participants were evaluated in a seated position, with their
right arm at the heart level, then asked to relax and stay still during the measurement.
At least two measurements were made (separate repeated measurements every 1–2 min),
taking the average value between both as long as the difference did not exceed 5 mm/Hg.
2.2.3. Anthropometric Measurements
Waist circumference was measured halfway between the lower costal margin and the
iliac crest in an orthostatic position to the nearest 0.1 cm, according to the International
Society for the Advancement of Kinanthropometry protocol [34]. Body mass index was
calculated from weight and height (kg/m2). Height was recorded accurately to 1 mm with
a portable stadiometer (SECA 217, Hamburg, Germany). Body mass was measured on a
balance-beam scale accurate to 0.1 kg (Seca Optima 760, Hamburg, Germany).
2.2.4. Physical Activity
Physical activity was assessed in face-to-face interviews using the Baecke question-
naire [35]. This questionnaire includes a total of 16 questions classified into three specific
domains: physical activity at work/household activities (HS), sport, and leisure time.
Numerical coding for most response categories varied from 1 to 5 (Likert scale), ranging
from never to always or very often. The questionnaire also provides a measure of total
physical activity (PA), which is the sum of these three specific domains. Numerical coding
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for most response categories varied from 1 to 5 (Likert scale), ranging from never to always
or very often.
2.2.5. Socioeconomic Status
Socioeconomic status was assessed with the Brazilian Economic Classification Cri-
terion developed by the Brazilian Association of Research Companies [36], considering
each individual’s education level. To assess the education level, participants were asked
to indicate their level of schooling. The following scores were considered for this pur-
pose: 0 = illiterate/incomplete primary; 1 = complete primary/incomplete junior high;
2 = complete junior high/incomplete secondary; 3 = complete secondary/incomplete
higher; 4 = complete higher.
2.2.6. Determination of Metabolic Syndrome
The following criteria were defined for the diagnosis of metabolic syndrome, based on
conventional cut-off values suggested by the consensus of the International Diabetes Federa-
tion Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute;
American Heart Association; World Heart Federation; International Atherosclerosis Society;
and International Association for the Study of Obesity (IDF/NHLBI/AHA/WHF/IAS/
IASO [1]): (a) waist circumference ≥94 cm in men and ≥80 cm in women; (b) triglycerides
≥150 mg/dL (1.7 mmol/L); (c) cholesterol-HDL <40 mg/dL (1.0 mmol/L) in men and
<50 mg/dL (1.3 mmol/L) in women; (d) systolic blood pressure ≥130 mmHg and/or dias-
tolic ≥85 mmHg; and (e) fasting blood glucose ≥100 mg/dL. A coding of 1 was assigned
to the presence of the respective risk factor and 0 to its absence. These codes were used for
the final diagnosis of metabolic syndrome, with the presence of any of 3 out of the 5 listed
risk factors constituting a diagnosis of metabolic syndrome [1].
2.3. Statistics
Based on the criteria of IDF/NHLBI/AHA/WHF/IAS/IASO [1], the prevalence of
metabolic syndrome was expressed by a percentage. All data were tested for normality,
and preliminary analyses were performed to ensure no violation of the assumptions.
An independent-samples t-test was conducted to compare the means in the descriptive
characteristics of the samples, according to the presence/absence of metabolic syndrome.
In addition, to study the association between sex and categories of metabolic syndrome,
the chi-squared test for independent measures was used. Finally, using direct logistic
regression, several models were tested in order to identify what factors better explained the
likelihood that participants would present metabolic syndrome. The final model contained
age, sex (nonmodifiable variables), body mass index (BMI), education, and physical activity
(modifiable variables). Odds ratios and 95% confidence intervals were also presented in
order to quantify the change in odds of having metabolic syndrome when the value of a
predictor increases by one unit. All statistical analyses were performed using IBM SPSS
(IBM Corp., Armonk, NY, USA), version 26. The significance level was defined as p < 0.05.
3. Results
3.1. Descriptives
The means, standard deviations, and CI (95%) of the descriptive characteristics of the
samples by sex are presented in Table 1. An independent-samples t-test was conducted to
compare the descriptive characteristics for men and women. Men had significantly higher
systolic and diastolic blood pressure, higher waist circumference, and higher physical
activity than women. On the other hand, women had a significantly higher resting heart
rate, higher fasting blood glucose, higher cholesterol-total, higher cholesterol-HDL, higher
cholesterol-LDL, higher BMI, and a higher education level than men.
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(n = 558) p
Mean SD CI (95%) Mean SD CI (95%)
Age (y) 61.0 20.1 60.0–64.1 59.1 19.3 59.1–62.1 0.141
SBP (mm Hg) 133.8 17.0 132.2–135.8 127.8 17.3 126.7–129.6 <0.001
DBP (mm Hg) 77.1 12.2 75.3–77.9 74.4 11.8 72.9–74.9 0.001
HR (bpm) 72.3 11.1 71.1–73.4 75.6 10.8 74.3–76.4 <0.001
GLI (mg·dL−1) 94.9 37.1 90.6–98.5 101.6 42.6 98.3–105.5 0.015
CHOL—total
(mg·dL−1) 171.9 45.2 166.9–176.3 190.8 54.6 187.0–195.9 <0.001
HDL (mg·dL−1) 42.4 13.0 41.0–43.8 47.2 12.4 46.3–48.4 <0.001
LDL (mg·dL−1) 104.9 37.1 100.7–108.7 118.5 40.2 115.3–122.0 <0.001
TG (mg·dL−1) 149.2 106.6 132.7–152.1 150.9 92.1 140.3–154.5 0.800
WACI (cm) 89.0 12.4 88.1–90.7 85.1 11.9 84.6–86.5 <0.001
BMI (kg·m−2) 26.8 4.7 26.4–27.4 28.1 5.5 27.8–28.7 <0.001
PA (units) 7.9 1.1 7.8–8.0 7.5 1.1 7.5–7.7 <0.001
Education (n) 1.1 1.3 0.91–1.20 1.5 1.4 1.3–1.56 <0.001
Independent-samples t-test; MS, metabolic syndrome; SBP, systolic blood pressure; DBP, diastolic
blood pressure; GLI, fasting blood glucose; CHOL, cholesterol; HDL, high-density lipoproteins; LDL,
low-density lipoproteins; TG, triglycerides; WACI, waist circumference; HR, heart rate; BMI, body
mass index; PA, physical activity; 95% C.I., 95% confidence interval for means.
3.2. The Prevalence of Each Risk Factor for Metabolic Syndrome
Sex-related differences in the prevalence of each risk factor for metabolic syndrome
are presented in Table 2. Blood pressure (62.5%) in men and abdominal obesity (67.3%)
in women were the most prevalent risk factors of metabolic syndrome in this sample.
Additionally, a low value of high-density lipoproteins (HDL; 52.2% and 65.0%) was the
second risk factor with a higher prevalence in this sample in men and women, respectively.







n (%) CI (%) n (%) CI (%) n (%) CI (%)
Below cut-off
WACI 221 (62.8) 57.5–67.9 193 (32.7) 28.9–36.7 414 (43.9) 40.8–47.2
Above cut-off
WACI 131 (37.2) 32.2–42.5 397 (67.3) ** 63.3–71.1 528 (56.1) 52.8–59.3
Below cut-off TG 221 (64.2) 58.9–69.3 356 (61.9) 57.8–65.9 577 (62.8) 59.6–65.9
Above cut-off TG 123 (35.8) 32.9–43.4 219 (38.1) 65.1–72.8 342 (37.2) 34.1–40.4
Below cut-off
HDL-C 163 (47.8) 43.4–53.3 199 (35.0) 31.1–39.1 362 (39.8) 36.6–43.0
Above cut-off
HDL-C 178 (52.2) 46.8–57.6 370 (65.0) ** 61.0–69.0 548 (60.2) 56.9–63.4
Below cut-off BP 132 (37.5) 32.4–42.8 303 (51.4) 47.2–55.5 435 (46.2) 43.0–49.4
Above cut-off BP 220 (62.5) 57.2–67.6 287 (48.6) ** 44.5–52.8 507 (53.8) 50.6–57.0
Below cut-off GLI 250 (72.0) 67.0–76.7 393 (67.4) 63.4–71.2 643 (69.1) 66.1–72.1
Above cut-off GLI 97 (28.0) 23.3–33.0 190 (32.6) 28.8–36.6 287 (30.9) 27.9–33.9
Below cut-off MS 206 (60.4) 55.0–65.6 227 (47.8) 43.6–52.0 478 (52.5) 49.2–55.8
Above cut-off MS 153 (39.6) 34.4–45.0 297 (52.2) ** 48.0–56.4 432 (47.5) 44.2–50.8
** Chi-squared p < 0.05; CI, confidence interval; WACI, waist circumference; TG, triglycerides; HDL-C,
high-density lipoproteins cholesterol; BP, blood pressure; GLI, fasting blood glucose; MS, metabolic
syndrome diagnosis made according to the criteria defined by the International Diabetes Federation
Task Force on Epidemiology and Prevention, the National Heart, Lung, and Blood Institute, the
American Heart Association, the World Heart Federation, the International Atherosclerosis Society,
and the International Association for the Study of Obesity (IDF/NHLBI/AHA/WHF/IAS/IASO) [1].
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The total prevalence of metabolic syndrome in this sample was 47.5% (39.6% in
men and 52.2% in women). The chi-squared for independent measures showed higher
prevalence in women in abdominal obesity [χ2 (1, n = 942) = 80.94; p < 0.001, phi = 0.29],
low HDL [χ2 (1, n = 910) = 14.64; p < 0.001, phi = 0.13], and metabolic syndrome [χ2 (1,
n = 910) = 13.59; p < 0.001, phi = 0.12]. However, men had elevated blood pressure [χ2 (1,
n = 942) = 17.03; p < 0.001, phi = −0.13].
3.3. Predicting the Likelihood of Presenting Metabolic Syndrome
Logistic regression was performed to assess the role of age, sex, BMI, education level,
and physical activity for the likelihood that participants would present metabolic syndrome.
The full model containing all predictors was statistically significant (X2 (5, n = 906) = 198.34,
p < 0.001), indicating that the model was able to distinguish between the presence/absence
of metabolic syndrome. The model as a whole explained between 19.7% (Cox and Snell
R square) and 26.2% (Nagelkerke R square) of the variance in metabolic syndrome status
and correctly classified 71% of the cases. As shown in Table 3, with one exception (physical
activity), all predictors made a unique statistically significant contribution to the model.
The strongest predictor of metabolic syndrome in this sample was sex, recording an odds
ratio of 1.67. This suggests that for women, the odds of presenting metabolic syndrome
increases by a factor of 1.7. The second stronger predictor of metabolic syndrome was BMI
(OR: 1.18, p < 0.001). This suggests that for each 1 kg/m−2 increase in BMI, the odds of
presenting metabolic syndrome increases by a factor of 1.2. Interestingly, education was
also a significant predictor, with an odds ratio of 1.12. This indicates that participants with
low education levels were more likely to present the metabolic syndrome. For every cycle
increased level of education, the odds of presenting metabolic syndrome decreased by a
factor of 1.12. Finally, age (OR: 1.03, p < 0.001) was also a significant predictor of metabolic
syndrome. This suggests that for each one-year increase in age, the odds of presenting
metabolic syndrome increases by a factor of 1.03.
Table 3. Logistic regression predicting the likelihood of presenting metabolic syndrome.




Age (y) 0.03 0.00 32.43 1.00 <0.001 1.03 1.02 1.04
Sex (M = 1; W = 0) −0.52 0.16 10.63 1.00 0.001 1.67 1.23 2.27
BMI (kg/m−2) 0.17 0.02 93.68 1.00 <0.001 1.18 1.14 1.22
Education (n) −0.12 0.06 4.05 1.00 0.044 1.12 1.00 1.35
PA (units) 0.03 0.07 0.13 1.00 0.717 1.03 0.89 1.18
Constant −6.82 0.79 74.99 1.00 <0.001 0.001
PA, physical activity; BMI, body mass index; B, unstandardized regression weight Wald, Wald statistic
test; df, degrees of freedom; 95% C.I. for EXP(B), 95% confidence interval for the odds ratio.
4. Discussion
This cross-sectional study sought to identify the most prevalent risk factors for
metabolic syndrome and assess the relative impact of age, sex, BMI, education level,
and physical activity on the likelihood that participants present metabolic syndrome. Our
results showed that blood pressure in men, abdominal obesity in women, and lower HDL-C
in both were the most prevalent individual risk factors for metabolic syndrome. Impor-
tantly, women had a higher prevalence of abdominal obesity, low HDL-C, and metabolic
syndrome than men. On the other hand, men showed more elevated blood pressure than
women. Finally, our results showed that advancing age, sex (female), having a higher BMI,
and a lower educational level independently increase the odds of metabolic syndrome.
First, our results support that men have more elevated blood pressure levels in
comparison to women. Similar results were seen in India [37], Korea [38], and the United
States [39]. However, recently, opposite results were seen in Bangladesh, showing a
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higher prevalence of hypertension among women [40]. Several sex-related determinants
of hypertension (i.e., age, dietetic habits, education, BMI, glucose) have been identified as
important moderators able to explain those differences. The more elevated blood pressure
levels found in our study, in particular in men, should trigger concrete nonpharmacological
intervention actions at the community level. Among nonpharmacological interventions,
there are important lifestyle modifications such as a healthy diet, weight loss, a reduction
of sodium and alcohol intake, an increase of potassium intake, and an increase of weekly
physical activity (in particular, aerobic exercise, dynamic resistance training, and isometric
resistance training) [41].
Regarding central obesity, our results corroborate that women have a higher preva-
lence of abdominal obesity than men [42]. This might be explained by the more favorable
fat distribution in women. Since abdominal obesity is highly correlated with metabolic
diseases, efforts to reduce or prevent the deposition of intra-abdominal body fat might
serve to reduce or prevent metabolic syndrome, particularly in women.
Considering all the five risk factors for metabolic syndrome, the second most preva-
lent in both men and women was the low concentration of HDL-C, which seems to be
protective in the development of cardiovascular diseases [43]. The prevalence of concen-
trations of HDL-C levels above the cut-off points in women is significantly higher than in
men, which corroborates the results achieved in other studies [44]. This finding could be
explained in part by changes in their hormonally mediated cholesterol metabolism after
menopause [31,45].
The prevalence of metabolic syndrome found in our study is very high (47.5%). The
National Health Survey (2013) reported much lower metabolic syndrome prevalence (8.5%)
in a sample of 59.402 Brazilians, being significantly higher in women than in men. Other
studies developed in Iran [8] (30.1% in men and 55% in women) and Mexico [9] (48.9%
in men and 60.4% in women) showed a higher prevalence of metabolic syndrome than
our results and confirmed the tendency of women to present higher values compared
with men, as we found in our study. In the context of Brazil, the closest results found in
comparison with our study were presented by de Carvalho Vidigal et al. [13] According
to that systematic review, the average prevalence of metabolic syndrome in Brazil was
29.6%. Even so, the results are much lower than ours. This can be explained in part by the
socioeconomic and health inequalities that place serious challenges to the public health
system [16] as well as the lower proportion of people practicing exercise in leisure time, as
reported by the National Health Research 2019 [46]. In addition, it is important to consider
that the comparisons between studies should contemplate the different diagnosis criteria
previously defined, which may lead to results discrepancies.
Our study was developed according to the recent guidelines defined for metabolic
syndrome diagnosis (IDF/NHLBI/AHA/WHF/IAS/IASO). The data collection was per-
formed in a geographic region in Brazil where information about this topic is highly scarce.
These data have huge importance since metabolic syndrome is a well-known risk factor for
cardiovascular disease, type 2 diabetes, and other harmful conditions such as nonalcoholic
fatty liver disease. This information underlines the urgent need for public health strategies
at the Amazonas community level to prevent this major health issue.
Second, this study aimed to assess the impact of age, sex, BMI, education level, and
physical activity on the likelihood that participants present metabolic syndrome. In general,
our results showed that advancing age, sex (female), having a higher BMI, and a lower
educational level independently increase the odds of metabolic syndrome. However,
physical activity was not a significant predictor of metabolic syndrome when all those
factors were considered. Although numerous studies have shown that increasing amounts
of weekly physical activity have a favorable impact on metabolic syndrome [31,47], the
difficulty in differentiating physical activity patterns, and a high level of sedentarism in
this population can mask this relationship [48].
Independently of age, educational level, or physical activity, sex (i.e., being female) and
BMI were the strongest predictors of having metabolic syndrome. In fact, in this sample,
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there was an association between these two factors; that is, women having significantly
higher BMI values (results not shown) and a higher prevalence of abdominal obesity
than men. Additionally, among a variety of possible factors to explain this sex-related
increased risk, menopause has been associated with an increase in risk for several diseases
such as cardiovascular disease, osteoporosis, diabetes, metabolic syndrome, and ovarian
cancer [49]. Moreover, in this study, we found women are less active than men (results
not shown), which is an important risk factor for obesity and metabolic syndrome. Our
results corroborate that obesity may precede the development of other metabolic syndrome
components [32], and interventions that address obesity and reduce waist circumference
may reduce the incidence of metabolic syndrome.
Interestingly, our results indicate that independently of age, sex, BMI, or physical ac-
tivity, participants with low education levels were more likely to have metabolic syndrome.
According to our results, a recent meta-analysis [30], aiming to assess the association
between metabolic syndrome and socioeconomic gradient, showed that the most disadvan-
taged people who had a lower education level, were unemployed, and of a lower income
level had more vulnerability to develop metabolic syndrome. Our results support the
conceptual idea that the education level of a population about the health hazards related
to metabolic syndrome could be an important way to prevent this public health problem.
Finally, it is well accepted that advancing age is an independent risk factor for metabolic
syndrome [14]. This is explained by age-associated declines in several physiologic variables
as well as unhealthy lifestyles adopted during the lifespan that substantially increases the
metabolic risk factors [29]. Altogether, our results bring new insights into the Amazonas
region, proposing prevention campaigns for metabolic syndrome focused on the oldest
people, women, obese people, and those with a lower education level.
There were some limitations associated with this study. First of all, we acknowledge
that the cross-sectional design of the present study limits conclusions regarding the direc-
tion of relationships between metabolic syndrome and modifiable explanatory factors for
this phenomenon. Secondly, due to the lack of consensus about the criteria used in the defi-
nition of metabolic syndrome, as well as the huge range of ages involved, some differences
when comparing to other studies should be considered. Third, although the majority of the
prior studies have assessed physical activity by questionnaires, the limited ability of some
participants to accurately recall past sport and leisure activities could introduce bias and
lead to misclassification. The introduction of a more objective instrument to assess physical
activity, i.e., accelerometers, even if in a subsample, should be considered in future studies.
To the strengths of the present study, it is important to mention that this is the first
study in a large sample of adults and older adults from the state of Amazonas. In addition,
clinical parameters to identify those with metabolic syndrome were assessed by special-
ized clinical analysis laboratory technicians. Glucose, HDL and LDL, and triglyceride
levels were assessed from blood samples, which guarantee the quality and validity of the
information collected.
5. Conclusions
This is the first study in a large sample of adults and older adults from the state of
Amazonas on metabolic syndrome and their relationship with independent explanatory
factors. The prevalence of metabolic syndrome found is high considering the literature.
This study supports targeted interventions to face this major public health problem. In
particular, blood pressure, abdominal obesity, and a lower concentration of HDL-C were
the metabolic abnormalities most prevalent in this sample. This study demonstrated
that advancing age, being female, having a higher BMI, and a lower educational level
are key variables to be considered in public health interventions. More research in this
important field of vulnerability and health research is needed specific to this region due to
the divergent results from the general Brazilian population.
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